BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21147145)

  • 1. Natriuretic peptide drug leads from snake venom.
    Vink S; Jin AH; Poth KJ; Head GA; Alewood PF
    Toxicon; 2012 Mar; 59(4):434-45. PubMed ID: 21147145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendroaspis natriuretic peptide and its functions in pig ovarian granulosa cells.
    Piao FL; Park SH; Han JH; Cao C; Kim SZ; Kim SH
    Regul Pept; 2004 May; 118(3):193-8. PubMed ID: 15003836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of dendroaspis natriuretic peptide and its binding to NPR-A receptor in rabbit kidney.
    Kim SM; Kim YA; Kim SY; Kim SH; Cho KW; Kim SZ
    Regul Pept; 2011 Feb; 167(1):42-9. PubMed ID: 21130122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
    Dickey DM; Potter LR
    J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptides and therapeutic applications.
    Lee CY; Burnett JC
    Heart Fail Rev; 2007 Jun; 12(2):131-42. PubMed ID: 17440808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natriuretic peptides--their receptors and role in cardiovascular system].
    Jerczyńska H; Pawłowska Z
    Postepy Biochem; 2008; 54(1):35-42. PubMed ID: 18610580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps).
    Schweitz H; Vigne P; Moinier D; Frelin C; Lazdunski M
    J Biol Chem; 1992 Jul; 267(20):13928-32. PubMed ID: 1352773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation.
    Singh G; Maguire JJ; Kuc RE; Skepper JN; Fidock M; Davenport AP
    Br J Pharmacol; 2006 Dec; 149(7):838-44. PubMed ID: 17043672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor.
    Johns DG; Ao Z; Heidrich BJ; Hunsberger GE; Graham T; Payne L; Elshourbagy N; Lu Q; Aiyar N; Douglas SA
    Biochem Biophys Res Commun; 2007 Jun; 358(1):145-9. PubMed ID: 17475216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative studies.
    Takei Y; Inoue K; Trajanovska S; Donald JA
    Gen Comp Endocrinol; 2011 May; 171(3):258-66. PubMed ID: 21362425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendroaspis natriuretic peptide system and its paracrine function in rat colon.
    Kim JH; Yang SH; Yu MY; Lee HK; Kim SY; Kim SH
    Regul Pept; 2004 Aug; 120(1-3):93-8. PubMed ID: 15177925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
    Lee CY; Huntley BK; McCormick DJ; Ichiki T; Sangaralingham SJ; Lisy O; Burnett JC
    Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):98-105. PubMed ID: 27340557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure.
    Singh G; Kuc RE; Maguire JJ; Fidock M; Davenport AP
    Circ Res; 2006 Jul; 99(2):183-90. PubMed ID: 16778132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal actions of synthetic dendroaspis natriuretic peptide.
    Lisy O; Jougasaki M; Heublein DM; Schirger JA; Chen HH; Wennberg PW; Burnett JC
    Kidney Int; 1999 Aug; 56(2):502-8. PubMed ID: 10432389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats.
    Jin H; Li B; Cunningham B; Tom J; Yang R; Sehl P; Thomas GR; Ko A; Oare D; Lowe DG
    J Clin Invest; 1996 Aug; 98(4):969-76. PubMed ID: 8770869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendroaspis natriuretic peptide is degraded by a metalloproteinase in the rat kidney.
    Kim SM; Kim SY; Kim SH; Kim SZ
    Mol Med Rep; 2014 Mar; 9(3):1037-43. PubMed ID: 24346109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendroaspis natriuretic peptide is the most potent natriuretic peptide to cause relaxation of lower esophageal sphincter.
    Huang SC
    Regul Pept; 2011 Apr; 167(2-3):246-9. PubMed ID: 21329732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal actions of dendroaspis natriuretic peptide in rabbits.
    Kim SM; Kim SY; Kim SH; Cho KW; Kim SZ
    Peptides; 2012 Jan; 33(1):59-66. PubMed ID: 22197490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.